Curaleaf Holdings (CURLF) Operating Expenses (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Operating Expenses of $156.5 million for Q1 2026, up 7.07% year-over-year from $146.2 million in Q1 2025, and up 2.15% quarter-over-quarter from $153.2 million in Q4 2025.
Curaleaf Holdings (CURLF) Operating Expenses (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Operating Expenses history runs 8 years deep, the most recent figure standing at $156.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 7.07% year-over-year to $156.5 million; the TTM figure through Mar 2026 stood at $614.8 million (changed 0.12% YoY), while the FY2025 annual figure was $605.6 million, down 1.7% from the prior year.
- Operating Expenses for Q1 2026 stood at $156.5 million, up from $153.2 million in the prior quarter.
- The five-year high for Operating Expenses was $142.2 billion in Q4 2023, with the low at $134.8 million in Q3 2023.
- The 5-year median for Operating Expenses is $152.0 million (2023), against an average of $9.6 billion.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses jumped 88994.43% in 2023, then plunged 99.88% in 2024.
- Curaleaf Holdings' Operating Expenses stood at $159.6 million in 2022, then surged by 88994.43% to $142.2 billion in 2023, then slumped by 99.88% to $163.6 million in 2024, then fell by 6.34% to $153.2 million in 2025, then climbed by 2.15% to $156.5 million in 2026.
- Business Quant data shows CURLF's Operating Expenses at $156.5 million in Q1 2026, $153.2 million in Q4 2025, and $155.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | 165.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 165.69 Mn |
| Mar 31, 2026 | 156.54 Mn |
| Dec 31, 2025 | 153.25 Mn |
| Sep 30, 2025 | 155.71 Mn |
| Jun 30, 2025 | 149.27 Mn |
| Mar 31, 2025 | 146.20 Mn |
| Dec 31, 2024 | 163.63 Mn |
| Sep 30, 2024 | 151.29 Mn |
| Jun 30, 2024 | 152.92 Mn |
| Mar 31, 2024 | 148.20 Mn |
| Dec 31, 2023 | 142.23 Bn |
| Sep 30, 2023 | 134.84 Mn |
| Jun 30, 2023 | 152.04 Mn |
| Dec 31, 2022 | 159.63 Mn |
| Sep 30, 2022 | 135.18 Mn |
| Jun 30, 2022 | 143.90 Mn |
| Dec 31, 2021 | 136.24 Mn |
| Sep 30, 2021 | 140.35 Mn |
| Jun 30, 2021 | 130.22 Mn |
| Mar 31, 2021 | 104.72 Mn |